期刊文献+

帕金森病基因治疗的研究进展 被引量:2

下载PDF
导出
作者 章为 周雪
出处 《四川解剖学杂志》 2002年第3期167-170,共4页 Sichuan Journal of Anatomy
基金 基础医学与法医学院回国人员启动基金
  • 相关文献

参考文献23

  • 1Horellou P, Sabate O, Bcu- Caron MH. Adenovirus- mediated gene transfer to the central nervous system for Parkinson's disease. Exp Neurol, 1997; 144 (1): 131-8. 被引量:1
  • 2Bowers WJ, Howard DF & Federoff HJ. Gene therapeutic strategies for neuroprotection: implications for Parkinson's disease. Exp Neurol, 1997; 144 (1): 58-68. 被引量:1
  • 3Leff SE, Spratt SK, Snyder RO, et al. Long - term restoration of stri- atal L - aromatic amino acid decarboxylase activity using recombinant adeno - associated viral vector gene transfer in a rodent model of Parkinson's disease. Neuroscience, 1999; 92 ( 1 ): 185 -96. 被引量:1
  • 4During MJ, Naegele K, OMalley et al. Long-term behavioral recovery in parkinsonian rats by an HSV - 1 vector expressing tyrosine hydroxylase. Science. 1994; 266:1399 - 1403. 被引量:1
  • 5Fraefel C, Song S, Geller Al, et al. Helper virus -free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol, 1996; 70 (10): 7190-97. 被引量:1
  • 6Ishida A, Yasuzumi F. Approach to ex vivo gene therapy in the treatment of Parkinson's disease. Brain Dev, 2000; 22 Suppl 1: 143 -7. 被引量:1
  • 7Costantini LC, Bakowska JC, Breakefield XO, et al. Gene therapy in the CNS. Gene Therapy, 2000; 7 (2): 93 -109. 被引量:1
  • 8Fisher LJ, Jinnah HA, Kale LC, et al. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron, 1991; 6:371 -380. 被引量:1
  • 9Lundberg CP, Horellou HM, Bjorklund A. Generation of DOPA - producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model. Exp Neurol, 1996; 139:39-53. 被引量:1
  • 10Bencsics C, Wachtel SR, Milstien S, et al. Double transduction tith GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L - DOPA by primary fibroblasts. J Neuroscl, 1996; 16: 4449-4456. 被引量:1

同被引文献17

  • 1BEAR MF,CONNORS BW,PARADISO MA.Neamscience exploring the brain[M].2nd Edition.Baltimore:Lippincott Williams Wilkins Inc,2001:482-493. 被引量:1
  • 2OZDENER H,YEE KK,CAO J,et al.Characterization and long-term maintenance of rat taste cells in culture[J].Chem Senses,2006,31(3):279-290. 被引量:1
  • 3于世凤.口腔组织病理学[M].第4版.北京:人民卫生出版社,2004:43-45. 被引量:1
  • 4Mandel RJ,Rendahl KG,Snyder RO,et al.Progress in direct striatal delivery of L-DOPA via gene therapy for treatment of Parkinson's desease using recombinant adeno-associated viral vectors[J].Exp Neurol,1999,159(1):47-64. 被引量:1
  • 5Prasad KN,Clarkson ED,La Rosa FG,et al.Efficacy of grafted immortalized dopamine neurons in an animal model of Parkinsonism:a review[J].Mol Genet Metab,1998,65 (1):1-9. 被引量:1
  • 6Costantini LC,Bakowska JC,Breakefield XO,et al.Gene therapy in the CNS[J].Gene Therapy,2000,7 (2):93-109. 被引量:1
  • 7Howard K.First Parkinson gene therapy trial launches [ J ].Nat Biotechnol,2003,21(10):1117-1118. 被引量:1
  • 8During MJ,Kaplitt MG,Stern MB,et al.Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation[J].Hum Gene Ther,2001,12 (12):1589-1591. 被引量:1
  • 9Luo J,Kaplitt MG,Fitzsimons HL,et al.Subthalamic GAD gene therapy in a Parkinson's disease rat model[J].Science,2002,298(5592):425-429. 被引量:1
  • 10Hopkins Tanne J.Diet supplements and gene therapy tried for Parkinson's disease[J].BMJ,2002,325(7369):851. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部